176 related articles for article (PubMed ID: 11862629)
1. Cytokine blocker licensed for relief of rheumatoid arthritis symptoms.
Am J Health Syst Pharm; 2002 Feb; 59(3):225-6. PubMed ID: 11862629
[No Abstract] [Full Text] [Related]
2. [Interleukin-1 inhibitors: a new alternative for the treatment of rheumatoid polyarthritis].
Gabay C
Rev Med Suisse Romande; 2000 Jun; 120(6):529-33. PubMed ID: 11014098
[No Abstract] [Full Text] [Related]
3. Anakinra shows promise for treating patients with rheumatoid arthritis.
McIntosh T; Freeman TR
J Am Pharm Assoc (Wash); 2002; 42(4):660-2. PubMed ID: 12150367
[No Abstract] [Full Text] [Related]
4. Treatment of rheumatoid arthritis with interleukin 1 receptor antagonist.
Bresnihan B
Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I96-8. PubMed ID: 10577983
[No Abstract] [Full Text] [Related]
5. The many worlds of reducing interleukin-1.
Dinarello CA
Arthritis Rheum; 2005 Jul; 52(7):1960-7. PubMed ID: 15986340
[No Abstract] [Full Text] [Related]
6. The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
Cohen SB
Rheum Dis Clin North Am; 2004 May; 30(2):365-80, vii. PubMed ID: 15172046
[TBL] [Abstract][Full Text] [Related]
7. [Anakinra for therapy of rheumatoid arthritis].
Tomoo T; Sumida T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():534-7. PubMed ID: 15799413
[No Abstract] [Full Text] [Related]
8. The trials of anakinra.
Burls A; Jobanputra P
Lancet; 2004 Sep 4-10; 364(9437):827-8. PubMed ID: 15351176
[No Abstract] [Full Text] [Related]
9. [The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis].
Riente L
Reumatismo; 2004; 56(1 Suppl 1):74-9. PubMed ID: 15201943
[TBL] [Abstract][Full Text] [Related]
10. Using anakinra for adult rheumatoid arthritis.
Kastanek L
Nurse Pract; 2002 Apr; 27(4):62-5. PubMed ID: 11984420
[No Abstract] [Full Text] [Related]
11. Anakinra: a review of its use in the management of rheumatoid arthritis.
Waugh J; Perry CM
BioDrugs; 2005; 19(3):189-202. PubMed ID: 15984903
[TBL] [Abstract][Full Text] [Related]
12. From the Food and Drug Administration.
Schwetz BA
JAMA; 2002 Jan; 287(1):33. PubMed ID: 11754690
[No Abstract] [Full Text] [Related]
13. Effects of anakinra on clinical and radiological outcomes in rheumatoid arthritis.
Bresnihan B
Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii74-7. PubMed ID: 12379629
[No Abstract] [Full Text] [Related]
14. [Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].
Zoń-Giebel A; Kotulska A; Giebel S; Cader SA; Kucharz EJ
Przegl Lek; 2002; 59(11):916-8. PubMed ID: 12715722
[TBL] [Abstract][Full Text] [Related]
15. Emerging therapies in juvenile rheumatoid/idiopathic arthritis.
Passo M
Curr Probl Pediatr Adolesc Health Care; 2006 Mar; 36(3):97-103. PubMed ID: 16473286
[No Abstract] [Full Text] [Related]
16. [When are "biologics" indicated?].
MMW Fortschr Med; 2006 Apr; 148(17):10. PubMed ID: 16711479
[No Abstract] [Full Text] [Related]
17. Clinical and radiological effects of anakinra in patients with rheumatoid arthritis.
Bresnihan B; Cobby M
Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii22-8. PubMed ID: 12817092
[TBL] [Abstract][Full Text] [Related]
18. The effect of interleukin-1 blockade on fatigue in rheumatoid arthritis--a pilot study.
Omdal R; Gunnarsson R
Rheumatol Int; 2005 Aug; 25(6):481-4. PubMed ID: 15071755
[TBL] [Abstract][Full Text] [Related]
19. Anakinra (interleukin-1 receptor antagonist) has positive effects on function and quality of life in patients with rheumatoid arthritis.
Kavanaugh A
Adv Ther; 2006; 23(2):208-17. PubMed ID: 16751154
[TBL] [Abstract][Full Text] [Related]
20. Anakinra for arthritis.
Pestell K
Trends Pharmacol Sci; 2001 Aug; 22(8):401. PubMed ID: 11478998
[No Abstract] [Full Text] [Related]
[Next] [New Search]
